Search filters

Filters
Clear All

Phase

  • 7
  • 4
  • 5
  • 15
  • 2
  • 33
  • 67
  • 36
  • 3
  • 65

Found 68 Menstruation trials

A listing of Menstruation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 INFORM Study

INFORM Study

18-100 years
Healthy Volunteer
All genders
Join a paid research study on health information on social media!The research study is being conducted to understand how health information and misinformation is shared and interacted with through Facebook wall posts, Twitter posts, and Google and YouTube searches. We’re interested in learning more about how people use information on …
Check Eligibility
Online study
 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

18-99 years
All genders
Phase 3
Semaglutide is a medicine studied in patients with NASH. Semaglutide is a well-known medicine, which is already used by doctors to treat type 2 diabetes in many countries. Participants will need to inject themselves with medicine under the skin. Participants will need to do this once a week. The study …
 LCAT Deficiency Disorders: natural history and identification of biomarkers

LCAT Deficiency Disorders: natural history and identification of biomarkers

1-99 years
All genders
Familial lecithin:cholesterol acyl transferase (LCAT) deficiency (FLD) is a rare, hereditary disease with no treatment. It is caused by mutations in the gene for LCAT, an enzyme that is made in the liver and plays a role in the body’s ability to process (“metabolize”) cholesterol. People with FLD have very …
 PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

18-99 years
All genders
Phase 3
Immunoglobulin A nephropathy (IgAN) is a rare disease that affects the kidneys, mostly in teens and adults. Kidneys are important to your health because they filter waste materials such as salts, toxins and water out of the blood. The waste is passed out of your body as urine (pee). IgAN …

Adjustable prosthetic sockets for children and adolescents with lower limb loss to accommodate growth

3-18 years
All genders
Phase 2
This study aims to develop an adjustable, immediate fit prosthetic device for children age 3- 18 which will accommodate growth.  We are looking for children with lower limb amputation- above knee, below knee and symes amputations.All testing will be done within the PM&R Gait Lab  located at 1800 Lombard St, …
 Metabolomic Reprogramming in insomnia as a Function of Objective Sleep Duration

Metabolomic Reprogramming in insomnia as a Function of Objective Sleep Duration

25-50 years
All genders
The research study is being conducted to understand how insomnia and the amount of sleep people get at night affect metabolism. Four groups of people will be asked to participate: individuals with insomnia who sleep >6 hours per night, individuals with insomnia who sleep <6 hours per night, individuals without …

ProNET: Psychosis Risk Outcomes Network

12-30 years
All genders
We are seeking young people who are concerned about recent changes in mood, thinking or behavior.  This research project aims to increase understanding of mental health concerns in young people and how to prevent the development of a more serious mental illness such as psychosis.
 TruGraf Long-term Clinical Outcomes Study

TruGraf Long-term Clinical Outcomes Study

18-99 years
All genders
Observational
The purpose of this study is to evaluate post-transplant clinical outcomes in recipients of kidney transplants who are undergoing TruGraf® and TRAC monitoring. These tests are commercially available blood tests that may help better monitor rejection. Targeted population are kidney transplant recipients. Procedures include blood will be drawn for TruGraf® …

A Randomized Double-Blind Placebo-Controlled Phase 3 Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients with Familial Chylomicronemia Syndrome (FCS)

99 years and younger
All genders
This is a multi-center, randomized, double-blind, placebo-controlled study of safety and efficacy of ISIS 678354 in patients with FCS. Eligible patients will enter an approximately 4-week Screening Period and an approximately 2-week qualification period. Approximately 60 eligible patients will be randomized 1:1 to Cohort A (50 mg) or Cohort B …

Evaluate Study Drug ABBV-154 in Subjects with Moderately to Severely Active Crohn's Disease (CD): AIM-CD

18-75 years
All genders
The purpose of this study is to see if the study drug ABBV-154 is safe and able to treat subjects with moderately to severely active Crohn's Disease who have an inadequate response to or were intolerant of prior biologics. ABBV-154 is an antibody-drug conjugate, which means it is composed of …
1 - 10 of 68